Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

National leaders in health, technology, education, and policy gathered Friday, Jan. 10, at the Crystal Bridges Museum of ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

"We sit at the intersection of those large scale incumbents and entrepreneurs, to help bridge the gap," Josh Flum, Managing Partner at LRVHealth, tells Bloomberg Intelligence in this episode of the ...

In this conversation, the Business Journal invites Cadrenal Founder & CEO Quang Pham to talk about the biopharmaceutical industry and financing.

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...